SUBSCRIBE
SUBSCRIBE

TG Therapeutics, Inc.

NEWS
Press Releases
New Data for BRIUMVI® Demonstrate 89.9% of Patients with Relapsing Multiple Sclerosis Were Free from Disability Progression After 6 Years of Continuous BRIUMVI Treatment
September 25, 2025
 · 
17 min read
Press Releases
TG Therapeutics Announces Schedule of Data Presentations for BRIUMVI® in Multiple Sclerosis at the 2025 European Committee for Treatment and Research in Multiple Sclerosis Annual Meeting
September 10, 2025
 · 
14 min read
Press Releases
TG Announces Phase 3 Trial for Subcutaneous BRIUMVI Commenced Enrollment
September 8, 2025
 · 
16 min read
Press Releases
TG Therapeutics to Participate in the H.C. Wainwright 27th Annual Global Investment Conference
September 4, 2025
 · 
1 min read
Press Releases
TG Therapeutics Announces Completion of Existing Share Repurchase Program and Authorization of New $100 Million Program
September 3, 2025
 · 
12 min read
Press Releases
TG Therapeutics to Participate in the Cantor Global Healthcare Conference
August 29, 2025
 · 
1 min read
Press Releases
TG Therapeutics Reports Second Quarter 2025 Financial Results and Raises BRIUMVI Revenue Guidance
August 5, 2025
 · 
20 min read
Press Releases
TG Therapeutics to Host Conference Call on Second Quarter 2025 Financial Results and Business Update
July 31, 2025
 · 
1 min read
Press Releases
TG Therapeutics to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference
June 9, 2025
 · 
1 min read
Press Releases
TG Therapeutics to Participate in the Jefferies Global Healthcare Conference
June 2, 2025
 · 
1 min read
Press Releases
TG Therapeutics Announces Data Presentations for BRIUMVI in Multiple Sclerosis at the 2025 Consortium of Multiple Sclerosis Centers Annual Meeting
May 30, 2025
 · 
13 min read
Press Releases
TG Therapeutics Announces Schedule of Data Presentations for BRIUMVI® in Multiple Sclerosis at the 2025 Consortium of Multiple Sclerosis Centers Annual Meeting
May 28, 2025
 · 
14 min read
Press Releases
TG Therapeutics Reports First Quarter 2025 Financial Results and Raises BRIUMVI Full Year Revenue Guidance
May 5, 2025
 · 
20 min read
Press Releases
TG Therapeutics to Host Conference Call on First Quarter 2025 Financial Results and Business Update
April 30, 2025
 · 
1 min read
Press Releases
TG Therapeutics Announces Data Presentations for BRIUMVI in Multiple Sclerosis at the American Academy of Neurology 2025 Annual Meeting
April 8, 2025
 · 
14 min read
Press Releases
TG Therapeutics Announces Two Publications Highlighting BRIUMVI in Medical Journals
April 7, 2025
 · 
14 min read
Load More
AWARDS
  • 2026 - Best Places to Work - Badge (1).png
JOBS